About Decapping and exoribonuclease protein
Decapping and exoribonuclease protein (DXO) is a protein
from Homo sapiens identified by UniProt accession
O77932, 396 residues long.
MolForge cross-references it against 0 known binders and
34 disease associations.
Target properties
| Protein name | Decapping and exoribonuclease protein |
| UniProt accession | O77932 |
| Gene | DXO |
| Organism | Homo sapiens |
| Length | 396 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (34)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.10
- psoriatic arthritis · score 0.10
- C3a anaphylatoxin des arginine measurement · score 0.05
- breast cancer · score 0.05
- interleukin 18 receptor accessory protein measurement · score 0.05
- monocyte count · score 0.05
- self reported educational attainment · score 0.05
- cognitive function measurement · score 0.05
- von Willebrand factor measurement · score 0.04
- complement C4 measurement · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O77932-F1 | alphafold | PREDICTED | 92.66 | — |
Amino-acid sequence (396 residues)
MDPRGTKRGA EKTEVAEPRN KLPRPAPSLP TDPALYSGPF PFYRRPSELG CFSLDAQRQY HGDARALRYY SPPPTNGPGP NFDLRDGYPD RYQPRDEEVQ ERLDHLLCWL LEHRGRLEGG PGWLAEAIVT WRGHLTKLLT TPYERQEGWQ LAASRFQGTL YLSEVETPNA RAQRLARPPL LRELMYMGYK FEQYMCADKP GSSPDPSGEV NTNVAFCSVL RSRLGSHPLL FSGEVDCTDP QAPSTQPPTC YVELKTSKEM HSPGQWRSFY RHKLLKWWAQ SFLPGVPNVV AGFRNPDGFV SSLKTFPTMK MFEYVRNDRD GWNPSVCMNF CAAFLSFAQS TVVQDDPRLV HLFSWEPGGP VTVSVHQDAP YAFLPIWYVE AMTQDLPSPP KTPSPK
Explore Decapping and exoribonuclease protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets